Form 4: Quest Diagnostics Director Buys Shares via DRIP

Vicky B. Gregg, a director at Quest Diagnostics Inc., acquired 70 shares of common stock through a dividend reinvestment plan at $189.082 per share.

Summary

• Vicky B. Gregg, a director of Quest Diagnostics Inc. (DGX), acquired 70 shares of common stock.
• The transaction occurred on October 21, 2025.
• Shares were acquired at a price of $189.082 per share.
• The acquisition was made pursuant to a dividend reinvestment plan (DRIP) administered by the reporting person's broker.
• Following this transaction, Ms. Gregg beneficially owns 18,287 shares of Quest Diagnostics common stock.
• This transaction was reported early on Form 4, though it was eligible for deferred reporting on Form 5 under Rule 16a-6.

Sentiment

Score: 6

Explanation: The acquisition of shares by a director, even through a dividend reinvestment plan, generally indicates a positive sentiment and confidence in the company's prospects. However, the transaction size is relatively small, limiting its overall impact on sentiment.

Positives

• A director increasing their stake in the company, even through a dividend reinvestment plan, can be viewed as a positive signal of confidence in the company's future prospects.
• The acquisition was part of a routine dividend reinvestment plan, indicating consistent investment.

Negatives

• No negative aspects are indicated in this routine insider transaction filing.

Risks

• No specific risks are mentioned in this Form 4 filing.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future outlook.

Industry Context

Insider transactions, such as those reported on Form 4, are routine disclosures in the financial industry, providing transparency into management and director holdings. While this specific transaction is small, consistent insider buying, even through DRIPs, can sometimes be interpreted as a sign of internal confidence in the company's valuation and future performance within the diagnostic services sector.

Comparison to Industry Standards

• This is a routine insider transaction disclosure. Direct comparisons to specific companies or projects based solely on this filing are not applicable, as it reports an individual director's share acquisition rather than company-wide performance or strategic initiatives.
• The transaction size is relatively small and part of a dividend reinvestment plan, which is a common mechanism for directors to increase their holdings.

Stakeholder Impact

• Shareholders may view the director's increased stake as a minor positive signal of management confidence in the company's value.

Next Steps

• No specific future actions, events, or milestones are mentioned in this Form 4 filing.

Key Dates

Keywords

Quest Diagnostics, DGX, Insider Transaction, Form 4, Director Stock Purchase, Dividend Reinvestment Plan, Vicky B. Gregg, Common Stock